Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02422979
Title Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aspyrian Therapeutics, Inc.
Indications

head and neck squamous cell carcinoma

Therapies

ASP-1929

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
Centura Health Research Center Denver Colorado 80210 United States Details
Rush University Cancer Center Chicago Illinois 60612 United States Details
Virginia Piper Cancer Institute, part of Allina Health System Minneapolis Minnesota 55407 United States Details
University of Oklahoma Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field